3 ms·
yeah artificial pancreas seems to be the most promising near-term development. the field has suffered from a lack of funding for translational research as VCs
by aaavl2821 9y ago
yeah artificial pancreas seems to be the most promising near-term development. the field has suffered from a lack of funding for translational research as VCs have been focused on other diseases, but hopefully that changes. semma (a startup turning stem cells into beta cells) raised $114M last week
- thingification 9y agoWhy are they focused on other diseases? Diabetes is hardly a rare disease, nor one with a low impact on its sufferers. So if what you say is true, what is it that's broken about the market for diabetes treatment? I often hear it said that problems such as this are caused by cures being less profitable compared to drugs, because drugs are purchased repeatedly, cures only once. But competition is supposed to solve that problem. Is inappropriate regulation the real problem?